MJ
Amplify Alternative Harvest ETF
Set alert
21.58 USD -0.95 -4.22%
21.47 Day range 22.09
21.05 52-week range 41.83
- YTD
- -27.56%
- 1 year
- -31.56%
- Open
- 22.09
- Prev close
- 22.53
- Mkt cap
- 98.37M
- Vol
- 22.62K
- Avg vol
- 33.67K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.47
- High
- 22.09
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.79
- 200-d avg
- 3.41
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 2.79
- 200-day average
- 3.41
About Amplify Alternative Harvest ETF
The index tracks the performance of the common stock (or corresponding American Depositary Receipts (“ADRs”), Global Depositary Receipts (“GDRs”)) of companies across the globe, including U.S. companies. The fund uses a “passive” or indexing approach to try to achieve the fund’s investment objective. The fund is non-diversified.
News
- 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
- Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD
- Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.
- 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
- "Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment
- Marijuana Stocks to Watch Before the Next Cannabis Rally
- 3 Top Picks For Marijuana Stocks Investors To See Profits In 2026
- Trump's Rescheduling of Marijuana Is a Spark for Top Marijuana ETFs
- Cannabis ETFs: Regulatory Momentum Returns Focus
- Focus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Your note
Sign in to keep a note on MJ — it syncs with the Stock Master app.